Osman E. K.
- Country
- France
- Department
- Radiotherapy oncology
Research Overview
- Phase III Multicenter Randomized Controlled Double-Blind Study of Bevacizumab Versus Placebo in Corticodependent or Corticoresistant Brain Radionecrosis Post-Radiotherapy for Brain Metastases
- Phase II Evaluation of Durvalumab Maintenance Therapy Post-Thoracic Chemoradiotherapy in Frail Patients with Limited Disease Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 7 of 46 partner sites.
Specializations
Neuro-Oncology
Specializes in the management of brain radionecrosis following radiation therapy for brain metastases. Focuses on investigating therapeutic approaches combining corticosteroid therapy with targeted treatments for patients experiencing post-radiation complications.
- Brain Metastasis Treatment
- Post-Radiation Complications
- Neurological Symptom Management
Explores innovative therapeutic strategies for radiation-induced brain tissue damage.
Thoracic Oncology
Concentrates on treating limited-stage small cell lung cancer in frail patients, with particular attention to those with specific health considerations including elderly patients and those with comorbidities.
- Small Cell Lung Cancer
- Immunotherapy Applications
- Chemoradiotherapy Protocols
Develops treatment protocols for vulnerable patient populations requiring specialized therapeutic approaches.
Precision Medicine
Focuses on tailoring cancer treatments for specific patient subgroups, particularly incorporating immunotherapy maintenance strategies and evaluating disease progression patterns.
- Treatment Response Assessment
- Personalized Therapy Protocols
- Clinical Outcome Evaluation
Implements targeted therapeutic approaches based on patient-specific factors and disease characteristics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.